Celltrion
068270.KS
#799
Rank
C$42.57 B
Marketcap
C$194.61
Share price
-1.20%
Change (1 day)
12.78%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): C$2.64

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$2.63. In 2023 the company made an earnings per share (EPS) of C$3.84 a decrease over its 2022 EPS that were of C$3.93.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$2.64
2023C$3.84-2.08%
2022C$3.93-11.72%
2021C$4.452.03%
2020C$4.3682.8%
2019C$2.3818.31%
2018C$2.01-36.33%
2017C$3.16161.25%
2016C$1.212.86%
2015C$1.1817.84%
2014C$1.005.87%
2013C$0.94-70.85%
2012C$3.24134.09%
2011C$1.3843.59%
2010C$0.9674.49%
2009C$0.55317.8%
2008C$0.13-71.7%
2007C$0.47